glucose lowering therapiessodium glucose co-transporter inhibitorsatherosclerotic cardiovascular diseaseDiabetes mellitusacute coronary syndrome (ACS)type 2 diabetes mellitus
…a valid glycated haemoglobin (HbA1c) (ii) early optimisation of glucose lowering therapies with proven cardiovascular benefit and (iii) impact on reno-car…